• N/A
    Market Cap
  • 6.55%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.04
$0.07
$0.05
1-Year Range
$0.01
$0.12
$0.05
Latest Close$0.05
Change
-$0.02 (-48.00%)
Volume1,764

Information as of 06/22/2026

Company Profile

Nova Mentis Life Science Corp.
https://www.restartlife.co
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
700-838 West Hasting Street, Vancouver, BC, Canada, V6C 0A6
778 819 0244

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Holy Crap. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.

Key Executives

  • Rebecca Lynn Hudson
  • Inez
  • Aylia Mohammadi
  • Steve Loutskou
  • Kelly Pladson

Current Ownership Distribution

  • Other36.5M (99.97%)
  • Institutions10,000 (0.03%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)